Impaired in vivo venous constriction in conscious obese Zucker rats with metabolic syndrome

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 373, Issue 6, 2006, Pages 451-456

  Song, Dongzhe ^a   Hutchings, Simon R ^a   Pang, Catherine C Y ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Mean circulatory filling pressure; Nitric oxide; Noradrenaline; Zucker rats

Indexed keywords

HYPERTENSIVE FACTOR; INSULIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CONSTRICTION; ARTICLE; BODY WEIGHT; CIRCULATION; COMPARATIVE STUDY; CONSCIOUSNESS; CONTROL GROUP; CONTROLLED STUDY; DOWN REGULATION; GROUPS BY AGE; IN VIVO STUDY; INSULIN BLOOD LEVEL; LEAN BODY WEIGHT; MALE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; RAT; RAT STRAIN; TRIACYLGLYCEROL BLOOD LEVEL; VENOCONSTRICTION;

ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HEART RATE; INSULIN; MALE; METABOLIC SYNDROME X; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE III; NOREPINEPHRINE; OBESITY; RATS; RATS, ZUCKER; REGIONAL BLOOD FLOW; TRIGLYCERIDES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VEINS;

EID: 33748752118     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-006-0088-8     Document Type: Article

References (41)

1. Alonso-Galicia M, Brands MW, Zappe DH, Hall JE (1996) Hypertension in Obese Zucker rats. Role of angiotensin II and adrenergic activity. Hypertens 28:1047-1054
2. Argiles JM (1989) The Obese Zucker rat: a choice for fat metabolism 1968-1988: twenty years of research on the insights of the Zucker mutation. Prog Lipid Res 28:53-66
3. Barringer DL, Bunag RD (1989) Uneven blunting of chronotropic baroreflexes in obese Zucker rats. Am J Physiol 256:H417-421
4. Bohlen HG, Nase GP (2002) Obesity lowers hyperglycemic threshold for impaired in vivo endothelial nitric oxide function. Am J Physiol Heart Circ Physiol 283:H391-H397
5. Brooks-Asplund EM, Shoukas AA, Kim SY, Burke SA, Berkowitz DE (2002) Estrogen has opposing effects on vascular reactivity in obese, insulin-resistant male Zucker rats. J Appl Physiol 92:2035-2044
6. Bunag RD, Barringer DL (1988) Obese Zucker rats, though still normotensive, already have impaired chronotropic baroreflexes. Clin Exp Hypertens A1:257-262
7. Carlson SH, Shelton J, White CR, Wyss JM (2000) Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic Obese Zucker rats. Hypertens 35:403-408
8. Calver A, Harris A, Maxwell JD, Vallance P (1994) Effect of local inhibition of nitric oxide synthesis on forearm blood flow and dorsal hand vein size in patients with alcoholic cirrhosis. Clin Sci (Lond) 86:203-208
9. Edmunds ME, Russell GI, Swales JD (1989) Vascular capacitance and reversal of 2-kidney, 1-clip hypertension in rats. Am J Physiol 256:H502-H507
10. Edmunds ME, Russell GI, Burton PR, Swales JD (1990) Vascular capacitance in rats subjected to chemical renal medullectomy. Hypertens 15:576-582
11. Fink GD, Johnson RJ, Galligan JJ (2000) Mechanisms of increased venous smooth muscle tone in desoxycorticosterone acetate-salt hypertension. Hypertens 35:464-469
12. Glick MR, Gehman JD, Gascho JA (1993) Endothelium-derived nitric oxide reduces baseline venous tone in awake instrumented rats. Am J Physiol 265:H47-H51
13. Grassi G, Seravalle G, Dell'Oro R, Turri C, Bolla GB, Mancia G (2000) Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertens 36:538-542
14. Grodins FS (1959) Integrative cardiovascular physiology: a mathematical synthesis of cardiac and blood vessel hemodynamics. Q Rev Biol 34:93-116
15. Guyton AC (1963) Venous return. In: Hamilton WF, Dow P (eds) Handbook of Physiology, Section 2 Circulation vol. II. Am Physiol Soc, Washington, DC, pp 1099-1133
16. He Y, MacLeod KM (2002) Modulation of noradrenaline-induced vasoconstriction in isolated perfused mesenteric arterial beds from Obese Zucker rats in the presence and absence of insulin. Can J Physiol Pharmacol 80:171-179
17. Iida M, Murakami T, Ishida K, Mizuno A, Kuwajima M, Shima K (1996) Substitution at codon 269 (glutamine→proline) of the leptin receptor (OB-R) cDNA is the only mutation found in the Zucker fatty (fa/fa) rat. Biochem Biophys Res Commun 224:597-604
18. Kooman JP, Wijnen JA, Draaijer P, van Bortel LM, Gladziwa U, Peltenburg HG (1992) Compliance and reactivity of the peripheral venous system in chronic intermittent hemodialysis. Kidney Int 41:1041-1048
19. Kopelman PG (2000) Obesity as a medical problem. Nature 404:635-643
20. Magder S, Kabsele K (1998) Evidence for constitutive release of nitric oxide in the venous circuit of pigs. J Cardiovasc Pharmacol 32:366-372
21. Martin DS, Rodrigo MC, Appelt CW (1998) Venous tone in the developmental stages of spontaneous hypertension. Hypertens 31:139-144
22. Milio G, Cospite V, Cospite M (1997) Hypertension and peripheral arterial disease: a plethysmographic study. Angiology 48:241-245
23. Morgan DA, Anderson EA, Mark AL (1995) Renal sympathetic nerve activity is increased in Obese Zucker rats. Hypertens 25:834-838
24. 2+ handling in the aorta of Obese Zucker rats with insulin resistance. Diabetes 45:S55-S58
25. Overbeck HW (1972) Hemodynamics of early experimental renal hypertension in dogs. Normal limb blood flow, elevated limb vascular resistance, and decreased venous compliance. Circ Res 31:653-663
26. Pamidimukkala J, Jandhyala BS (1996) Evaluation of hemodynamics, vascular reactivity and baroreceptor compensation in the insulin resistant Obese Zucker rats. Clin Exp Hypertens 18:1089-1104
27. Pan YJ, Young DB (1982) Experimental aldosterone hypertension in the dog. Hypertension 4:279-287
28. Pang CCY (2000) Measurement of body venous tone. J Pharmacol Toxicol Methods 44:341-360
29. Pang CCY (2001) Autonomic control of the venous system in health and disease: effects of drugs. Pharmacol Ther 90:179-230
30. Rosenblum CI, Tota M, Cully D, Smith T, Collum R, Qureshi S, Hess JF, Phillips MS, Hey PJ, Vongs A, Fong TM, Xu L, Chen HY, Smith RG, Schindler C, Van der Ploeg LH (1996) Functional STAT 1 and 3 signaling by the leptin receptor (OB-R); reduced expression of the rat fatty leptin receptor in transfected cells. Endocrinology 137:5178-5181
31. Schreihofer AM, Hair CD, Stepp DW (2005) Reduced plasma volume and mesenteric vascular reactivity in Obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 288:R253-261
32. Shah DI, Singh M (2006) Effect of bis(maltolato) oxovanadiumon experimental vascular endothelial dysfunction. Naunyn Schmiedebergs Arch Pharmacol 373:221-229
33. Simon G, Pamnani MB, Dunkel JF, Overbeck HW (1975) Mesenteric hemodynamics in early experimental renal hypertension in dogs. Circ Res 36:791-798
34. Stepp DW, Frisbee JC (2002) Augmented adrenergic vasoconstriction in hypertensive diabetic Obese Zucker rats. Am J Physiol Heart Circ Physiol 282:H816-820
35. Stepniakowski K, Egan BM (1995) Additive effects of obesity and hypertension to limit venous volume. Am J Physiol 268:R562-568
36. Subramanian R, MacLeod KM (2003) Age-dependent changes in blood pressure and arterial reactivity in Obese Zucker rats. Eur J Pharmacol 477:143-152
37. Vallance P, Palmer RM, Moncada S (1992) The role of induction of nitric oxide synthesis in the altered responses of jugular veins from endotoxaemic rabbits. Br J Pharmacol 106:459-463
38. G-nitro-L- arginine methyl ester (L-NAME) of resistance to venous return in rats. Br J Pharmacol 114:1454-1458
39. Yamamoto J, Goto Y, Nakai M, Ogino K, Ikeda M (1983) Circulatory pressure-volume relationship and cardiac output in DOCA-salt rats. Hypertens 5:507-513
40. Young DB, Murray RH, Bengis RG, Markov AK (1980) Experimental angiotensin II hypertension. Am J Physiol 239:H391-H398
41. Zemel MB, Peuler JD, Sowers JR, and Simpson L (1992) Hypertension in insulin-resistant Zucker obese rats is independent of sympathetic neural support. Am J Physiol 262:E368-E371